SUMMARY A reaction has been demonstrated between extracts of synovial cells removed from intact rheumatoid knee joints and autologous leucocytes. The cell mediated immunity test system used was leucocyte migration inhibition. Variable reactions were found with a spectrum of allogeneic extracts when donor leucocytes came from married or transfused females or transfused males. Leucocytes from healthy (nontransfused) males showed no reaction with any of the extracts. As a period of cell culture was used prior to preparation of this extract to remove nonspecific inhibitory substances, native immunoglobulins, and complexes, the data are best explained by the presence of a foreign pathogen or altered cell component in the synovial cells of these rheumatoid patients.
The pathology of the rheumatoid (RA) joint and particularly the appearance of the synovial membrane suggest that an immune response to persisting antigenic material is involved. Attempts directly to demonstrate a foreign antigen in various components of the joint have been conspicuously unsuccessful (for review see Marmion'. By a different approach cell mediated immune techniques have been widely utilised in which studies measure the reactivity of RA peripheral lymphocytes to joint components frequently derived from synovial cultures. Here also attempts to confirm early promising results, for example, of Bacon et al.,2 3 Kinsella,4 and Person and Sharp,5 have been generally unsuccessful. 6 In the examples listed crude extracts or explant cultures of synovial membranes derived from surgical procedures were used as a source of potential antigen containing cells to react with autologous and allogeneic leucocytes. In this study the unique method of Fraser and Catt8 for isolating and culturing synovial lining cells from intact knee joints has been the source of extracts to stud;y cell mediated immune responses.
Materials and methods

TEST SUBJECTS
The 10 RA patients used in this study (Table 1) fulfilled the American Rheumatism Association Accepted for publication 9 November 1979 Correspondence to Dr K. D. Muirden. 
SOURCE OF SYNOVIAL CELLS
The synovial cell extracts used as the antigen preparation were obtained by trypsinisation of intact normal (cadaver) knee joints8 and rheumatoid knee joints.9 The cells were cultured in Eagle's basal media containing 10% fetal calf serum and 10% human serum for at least 6 days. All RA cells were used in the primary phase, while controls had a mean passage level of 7. The highest subculture number was 13. Only young cultures were used to minimise the effects of long-term culture and passage.'0 11
PREPARATION OF SYNOVIAL CELL EXTRACTS
Because of reports that rheumatoid leucocyte migration may be inhibited by human immunoglobulinIgG or aggregated IgG12-14 both RA and normal cell cultures were carefully treated to eliminate any free or surface bound immunoglobulins ( Table 2 ). All cultures while still in monolayer form were washed in Hanks's balanced salt solution (HBSS) and for 24 hours placed in media containing 10% fetal calf instead of human serum. This process was repeated for a further 24 hours, and the cells were then washed again with HBSS and scraped off with a rubber spatula. Cell pellets were washed 3 times with HBSS before being disrupted by freeze/ thawing and sonication in 0H5M sodium chloride in phosphate buffered saline. After centrifugation at 600 g for 7 minutes the extract was then exhaustively dialysed for 3 days against distilled water before being freeze dried. Usually only 200-600 ,ug of extract was obtained from any one patient. Immediately before use the extract was made up to 50 ,ug/ml protein with medium 199, containing 20 mM HEPES (Sigma Chemical Company), 100 units per ml sodium penicillin G, and 100 Vg per ml streptomycin sulphate. Glucose, glutamine, and human serum albumin were added to a final concentration of 11 1 mM, 2'7 mM, and 0.4% respectively (Table 2) . Random cell suspensions were tested for the presence of human immunoglobulin by immunofluorescence with polyvalent antisera (Wellcome Reagents Ltd., Beckenham, England). No immunoglobulin was seen. Synovial cells which had been cultured in human serum were used as a positive control.
CELL MIGRATION INHIBITION TESTS
A modification of the leucocyte migration test of Soborg and Bendixon15 16 was used to assess cellular immunity to the extracts. The erythrocytes were sedimented in heparinised blood from patients or controls with 6 % dextran 150 in normal saline (1 ml per 5 ml of whole blood) for 30 min at 370C.
Leucocyte-rich plasma was removed, centrifuged to remove platelets, then the cells were washed twice and resuspended in HEPES buffered medium 199 before being packed into 25 1d capillary tubes (Microcaps, Drummond), which were sealed at one end with Seal-Ease (Clay Adams). These tubes containing the migrating cells were placed in chambers of 0 Kinsella4 . High concentrations of extract caused nonspecific inhibition of lymphocyte growth, and the maximum concentration that could be used was 12-5 ,ug/ml. By comparison the concentration used for migration inhibition tests was 50 tg/ml (see below). At this level no blastogenic response was seen in either RA or normal lymphocytes with any of the extracts. Positive controls were included containing 10 ,g/ml of conconavalin-A, and these showed stimulation indicies of between 7 and 30. The failure of this test could be related to the low level of extract required to avoid nonspecific effects. A more purified extract at a high concentration may in the future yield more definite results. Results The optimum extract concentration to induce migration inhibition was first determined by testing leucocytes from 2 control subjects and one RA patient against multiple dilutions of 4 extracts from both RA and normal cells. Strong nonspecific inhibition occurred at high extract concentrations. The highest concentration that did not cause nonspecific inhibition was 50 Ftg/ml, and this level was used throughout these experiments.
The leucocytes from 10 RA patients were tested for reactivity against autologous extracts. Significant inhibition occurred in nine (Fig. 1) . The same leucocytes were also tested against other RA extracts and normal cell extracts. Nine of the 34 tests reacted with migrations of 80% or less and 6 with migrations in the range of 80-85%. No clear correlation was seen between reactions and the presence of rheumatoid factor. Of the 3 seronegative patients 1 failed to react to any extract, 1 reacted to autologous RA extract, and 1 allogeneic control extract, while the third reacted to autologous RA extract, and 1 allogeneic RA extract. The leucocytes of male RA patients who had not received a blood transfusion reacted only against autologous extracts and failed to react against either RA or normal allogeneic extracts. All of the 7 transfused male and transfused or multiparous female patients showed reactions against 1 or more of the allogeneic extracts.
Leucocytes from the control group ofnormal, healthy nontransfused males showed no significant reaction to any of the control or RA extracts. Mean migration percentages are recorded in Table 3 .
In two patients it was possible to test extracts of synovial cells removed by different wash-out procedures separated by several months. The consistency of the response was shown in both, as with case 1 an 80% migration resulted with the 2 extracts, and in case 8 the migration was 80 %, 77 %, and 80 % for the 3 separate extracts. In our studies, by comparison with explant cultures in which there is a rapid growth of fibroblasts, multiplication is rare in cells removed from intact joints by trypsinisation.9 Although increase in size of cells occurs when they are grown in medium supplemented with human serum, subculturing did not take place, and, because of the short period of 10-21 days of culture, loss of any specific antigen contained in synovial cells could be minimised before the preparation of the synovial extract. The culture period after separation of cells from the RA joint did allow for contaminating synovial fluid, blood cells, and synovial cells apart from synoviocytes, to be washed free while allowing surface antigens stripped from the cell membrane by trypsin to be replaced. Corticosteroids are known to affect T cell function,32 33 but the only 2 patients in the series who were on corticosteroids were receiving very low doses-a daily intake of prednisolone of 3 mg or 5 mg. One of these (case 10) was on 4 antiarthritic drugs when tested initially and failed to react to autologous and several allogeneic extracts. The 4 drugs (prednisolone, D-penicillamine, aspirin, and indomethacin) were withdrawn for 48 hours and the tests repeated. Significant inhibition was then shown to both autologous and one allogeneic extract.
It is possible therefore that drugs may have affected responses, as otherwise no attempt was made to discontinue medication before venesection. Our own evidence with gold and the in-vitro studies of others indicate that depression rather than enhancement of responses might be related to the use of drugs, and therefore drugs could not be responsible for the positive inhibition with autologous extracts demonstrated here.
The nature of the 'rheumatoid' specific antigen(s) has yet to be determined. Preliminary fractionation of synovial extracts indicate that it has a large molecular weight or is membrane bound. Possible explanations are that the substance is a putative antigen acquired from the environment despite the consistently negative attempts directly to demonstrate microbial involvement in RA. Alternatively an infectious agent such as a virus might have induced a cell membrane change recognised by sensitised RA lymphocytes.21 Another explanation is that joint destruction may have induced an altered cell component, resulting in an autoimmune reaction, with sensitised lymphocytes as well as autoantibodies being produced.6.34 A further alternative is that the reaction could be due to an abnormality of the immune system with loss of immunoregulatory control generating autoreactive products.' There is as yet no decisive experimental evidence indicating participation of an infective agent, and the other alternatives remain speculative. Studies demonstrating that material cross-reacting like carcinoembryonic antigen (CEA) could be extracted from RA synovial membrane35 require clarification in the light of our experiments indicating that 9 out of 10 RA patients showed reactions to their own synovial extracts. It is probable but not certain that the antigen suggested by these leucocyte migration inhibition tests is not identical in each extract, as patients were tested against at least one RA preparation and not all showed cross-reactivity. 
